VTRS FY 2021 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$17.9B+49.7% YoY

Gross Profit

$5.6B31.2% margin

Operating Income

-$34M-0.2% margin

Net Income

-$1.3B-7.1% margin

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

$3.0B

Free Cash Flow

$2.5B

Stock-Based Comp.

$111M

Balance Sheet

Total Assets

$54.8B

Total Liabilities

$34.4B

Stockholders' Equity

$20.5B

Cash & Equivalents

$701M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17.9B	$11.9B	+49.7%
Gross Profit	$5.6B	$3.8B	+46.9%
Operating Income	-$34M	-$211M	+83.9%
Net Income	-$1.3B	-$670M	-89.4%